Connect with us

Industry Speaks

Innovation and advancements in diagnostics

The second wave of COVID-19 pandemic has shattered the expectation to resume a normal life in 2021. The loss of lives, the crumbling health infrastructure along with the massive COVID spread in India and nascent stage of vaccination are adding to this despair.

With the outbreak of COVID-19, a lot of challenges and areas have come into light including the need for trained medical technologists to keep up with the extensive demand of testing at laboratories and hospitals, adaptability of digitalization and need of automation & innovative technologies.

HORIBA Medical expects to play a key role in the healthcare and IVD space with special focus on up-skilling and re-skilling of healthcare professionals.

Product/Scientific – Vision and Support
In our inexorable endeavour to the appraisal of healthcare industry, we have introduced infectious disease screening like dengue, malaria including NLR flag on Yumizen H550 (6-part differential hematology analyzer).

We ensured the availability of much needed parameters like D-Dimer, Ferritin, LDH, and CRP to facilitate screening of COVID-19 infection and would continue to support our customers in coming times.

Our high-end hematology automation technology, HELO (HORIBA Evolutive Laboratory Organization) is not just a product for sample testing but a solution for every high-end, high-workload medical laboratory. It is a unique user-friendly solution which takes care of specific demographic variations that exist across the country. HELO has various technical aspects and additional upgradation alternatives that allow medical laboratories to upgrade themselves. As a part of HELO, we have middleware and expert validation station which connects Yumizen H1500/H2500 analyzers range and centralizes the data management with LIS connections.

We are also planning to create a unique and interactive “Club” for our high-end hematology customers for greater customer connect and enhanced support.

Quality and assessment of staff skills is another important requirement in laboratories. To meet this requirement, HORIBA Medical offers QCP (Quality Control Program) to validate internal Quality Control of laboratories and QSP (Quality Slide Program) to control slide review.

We are looking forward to expanding our portfolio to immunochemistry and molecular diagnostics in upcoming times.

Scientific study enhancement has been our constant forte and in the same quest we have come up with evolved HABX (Hematology Analyzer Based Xchanges) platform for the pathologists and hematologists across the globe to share knowledge.

New Insights to Technical Learning
We at HORIBA India have come up with a new initiative of bringing an educational platform called HITI (HORIBA India Technical Institute) with an aim to provide various specialized professional courses, conceptual understanding of different IVD technologies and best laboratory practices designed for career success.

The students at HITI will learn manual laboratory methods, modern technologies, advanced automated analyzers, Quality Management Systems & Standards and Internal Quality Audits, which will prepare them to be productive in modern laboratories and also for opportunities in the medical devices industry.

HORIBA India also has one of the six international training centres where global level training is imparted to our team and users from across the globe. We are also coming up with a state-of-the-art “Demo lab” at our Nagpur facility which will provide a live demonstration of our instruments at work.

Expansion – New Acquisition
HORIBA, Ltd. and HORIBA Instruments has acquired MedTest Holdings, Inc. (composed of MedTest Dx, Inc., Pointe Scientific, Inc., Clinitox Diagnostix, Inc., and Medical Laboratory Solutions, Inc.).

The acquisition combines complementary innovative technology offerings of the HORIBA Medical with MedTest Dx technology, Clinitox, and Pointe Scientific’s R&D and manufacturing capabilities, with expertise in FDA 510K and CLIA clearances, to address the multidisciplinary requirements of IVD testing customers.

MedTest Dx is a world leader in chemistry reagents manufacturing and diagnostic solutions for decentralized clinical testing, providing a combination of screening instruments and reagent manufacturing in medical technologies, with a wide portfolio of products for IVD testing laboratories.

Copyright © 2024 Medical Buyer

error: Content is protected !!